Lees B, Meredith LR, Kirkland AE, Bryant BE, Squeglia LM. Effect of alcohol use on the adolescent brain and behavior. Pharmacol Biochem Behav. 2020;192:172906.
Article CAS PubMed PubMed Central Google Scholar
World Health Organization. Global status report on alcohol and health 2018: World Health Organization; 2019.
Sun D, Adduru VR, Phillips RD, Bouchard HC, Sotiras A, Michael AM, et al. Adolescent alcohol use is linked to disruptions in age-appropriate cortical thinning: an unsupervised machine learning approach. Neuropsychopharmacology. 2022;11:1–10.
Lees B, Debenham J, Squeglia LM. Alcohol and cannabis use and the developing brain. Alcohol Res: Curr Rev. 2021;41:11.
Lees B, Mewton L, Stapinski LA, Squeglia LM, Rae CD, Teesson M. Neurobiological and cognitive profile of young binge drinkers: a systematic review and meta-analysis. Neuropsychol Rev. 2019;29:357–85.
Article PubMed PubMed Central Google Scholar
Crews FT, Robinson DL, Chandler LJ, Ehlers CL, Mulholland PJ, Pandey SC, et al. Mechanisms of persistent neurobiological changes following adolescent alcohol exposure: NADIA consortium findings. Alcohol: Clin Exp Res. 2019;43:1806–22.
Gowin JL, Sloan ME, Stangl BL, Vatsalya V, Ramchandani VA. Vulnerability for alcohol use disorder and rate of alcohol consumption. Am J Psychiatry. 2017;174:1094–101.
Article PubMed PubMed Central Google Scholar
Addolorato G, Vassallo GA, Antonelli G, Antonelli M, Tarli C, Mirijello A, et al. Binge drinking among adolescents is related to the development of alcohol use disorders: results from a cross-sectional study. Sci Rep. 2018;8:1–9.
Olsson CA, Romaniuk H, Salinger J, Staiger PK, Bonomo Y, Hulbert C, et al. Drinking patterns of adolescents who develop alcohol use disorders: results from the Victorian Adolescent Health Cohort Study. BMJ Open. 2016;6:e010455.
Article PubMed PubMed Central Google Scholar
Ehlers CL, Stouffer GM, Gilder DA. Associations between a history of binge drinking during adolescence and self‐reported responses to alcohol in young adult Native and Mexican Americans. Alcohol: Clin Exp Res. 2014;38:2039–47.
Fadus MC, Squeglia LM, Valadez EA, Tomko RL, Bryant BE, Gray KM. Adolescent substance use disorder treatment: an update on evidence-based strategies. Curr Psychiatry Rep. 2019;21:1–10.
Jensen CD, Cushing CC, Aylward BS, Craig JT, Sorell DM, Steele RG. Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J Consult Clin Psychol. 2011;79:433.
Tripodi SJ, Bender K, Litschge C, Vaughn MG. Interventions for reducing adolescent alcohol abuse: a meta-analytic review. Arch Pediatr Adolesc Med. 2010;164:85–91.
Tanner-Smith EE, Lipsey MW. Brief alcohol interventions for adolescents and young adults: a systematic review and meta-analysis. J Subst Abus Treat. 2015;51:1–18.
Chung T, Maisto SA. Relapse to alcohol and other drug use in treated adolescents: review and reconsideration of relapse as a change point in clinical course. Clin Psychol Rev. 2006;26:149–61.
Winters KC, Tanner-Smith EE, Bresani E, Meyers K. Current advances in the treatment of adolescent drug use. Adolesc Health, Med Ther. 2014;5:199.
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683–96.
Article CAS PubMed Google Scholar
Balog-Way DH, Evensen D, Löfstedt RE. Pharmaceutical benefit–risk perception and age differences in the USA and Germany. Drug Saf. 2020;43:1141–56.
Article CAS PubMed Google Scholar
O’Callaghan FV, Jordan N. Postmodern values, attitudes and the use of complementary medicine. Complement Ther Med. 2003;11:28–32.
Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169:805–12.
Article PubMed PubMed Central Google Scholar
Kalivas P, Volkow N. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011;16:974–86.
Article CAS PubMed PubMed Central Google Scholar
Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403–13.
Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561–72.
Article CAS PubMed Google Scholar
McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014;28:95–106.
Article CAS PubMed PubMed Central Google Scholar
Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294–321.
Lebourgeois S, González‐Marín MC, Jeanblanc J, Naassila M, Vilpoux C. Effect of N‐acetylcysteine on motivation, seeking and relapse to ethanol self‐administration. Addict Biol. 2018;23:643–52.
Article CAS PubMed Google Scholar
Quintanilla ME, Rivera‐Meza M, Berríos‐Cárcamo P, Salinas‐Luypaert C, Herrera‐Marschitz M, Israel Y. Beyond the “first hit”: marked inhibition by N‐acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol‐induced saccharin motivation. Alcohol: Clin Exp Res. 2016;40:1044–51.
Article CAS PubMed Google Scholar
Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M, et al. Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci. 2007;27:13968–76.
Article CAS PubMed PubMed Central Google Scholar
Ramirez-Niño AM, D’Souza MS, Markou A. N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking. Psychopharmacology. 2013;225:473–82.
Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012;100:801–10.
Article CAS PubMed Google Scholar
Smaga I, Frankowska M, Filip M. N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research. Pharmacol Rep. 2021;73:1205–19.
Article CAS PubMed PubMed Central Google Scholar
Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016;63:172–7.
Article PubMed PubMed Central Google Scholar
Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018;185:17–22.
Article CAS PubMed PubMed Central Google Scholar
Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the “Valley of Death” in medications development for alcohol use disorder. Alcohol: Clin Exp Res. 2018;42:1612–22.
Seyhan AA. Lost in translation: the valley of death across preclinical and clinical divide–identification of problems and overcoming obstacles. Transl Med Commun. 2019;4:1–19.
Cohen-Gilbert JE, Jensen JE, Silveri MM. Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse. Dev Psychopathol. 2014;26:405–23.
Article PubMed PubMed Central Google Scholar
Kohut SJ, Kaufman MJ. Magnetic resonance spectroscopy studies of substance use disorders: current landscape and potential future directions. Pharmacol Biochem Behav. 2021;200:173090.
Article CAS PubMed Google Scholar
Kirkland AE, Browning BD, Green R, Leggio L, Meyerhoff DJ, Squeglia LM. Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2022;27:3223–36.
Bustillo JR. Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci. 2022;15:329–37.
Schmaal L, Veltman DJ, Nederveen A, Van Den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology/ 2012;37:2143–52.
Article CAS PubMed Google Scholar
Coles LD, Tuite PJ, Öz G, Mishra UR, Kartha RV, Sullivan KM, et al. Repeated‐dose oral N‐acetylcysteine in Parkinson’s disease: pharmacokinetics and effect on brain glutathione and oxidative stress. J Clin Pharmacol. 2018;58:158–67.
Article CAS PubMed Google Scholar
Tuura ROG, Warnock G, Ametamey S, Treyer V, Noeske R, Buck A, et al. Imaging glutamate redistribution after acute N-acetylcysteine administration: a simultaneous PET/MR study. NeuroImage. 2019;184:826–33.
留言 (0)